The subject of the order is the delivery of Sirolimus and Vigabatrinum medicinal products used in the framework of the non-commercial ViRap clinical trial — 2 packages, on the basis set out in the proposed provisions of the contract in quantities resulting from current needs and within the deadlines arising from concluded agreement.

Sirolimus 1 mg/ml, oral solution, bottle 60 ml, licence no EU/1/01/171/001.

Vigabatrinum 500 mg, granules for oral solution, pack of 50 sachets, licence No 8327.